A voluntary nationwide recall of multiple ophthalmic products was issued on May 12, citing potential safety concerns stemming from serious manufacturing violations.
Over 70,000 Eye Products Recalled in USA After FDA AuditMay 13, 2025A voluntary nationwide recall of multiple ophthalmic products was issued on May 12, citing potential safety concerns stemming from serious manufacturing violations.
Bausch + Lomb Launches Zenlens CHROMA HOA Scleral Lens in the U.S.May 15, 2025Bausch + Lomb has officially launched Zenlens CHROMA HOA in the United States—a custom, wavefront-guided scleral contact lens specifically designed to correct higher-order aberrations (HOA).
Oral Zervimesine Slows Geographic Atrophy Progression in Phase 2 Dry AMD TrialMay 14, 2025Cognition Therapeutics has announced topline results from its Phase 2 Magnify study, evaluating the oral drug zervimesine in patients with geographic atrophy (GA) secondary to dry age-related macular degeneration (dry AMD).
Aqueous Humor Liquid Biopsy Proven Safe in Pediatric Retinoblastoma PatientsMay 15, 2025A study confirms that aqueous humor liquid biopsy, performed via anterior chamber paracentesis, is a safe and well-tolerated procedure for pediatric patients diagnosed with retinoblastoma or retinoblastoma-simulating lesions.
2024 Recap: Top 8 FDA Approvals in Ophthalmology Dec 16, 2024The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field